Einsele et al., 1989 - Google Patents
Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical samplesEinsele et al., 1989
- Document ID
- 9610088188559642216
- Author
- Einsele H
- Vallbracht A
- Jahn G
- Kandolf R
- Müller C
- Publication year
- Publication venue
- Journal of virological methods
External Links
Snippet
Hybridization techniques (slot-blot and in-situ hybridization assays) and immunostaining using murine monoclonal antibodies directed against different proteins of the human cytomegalovirus (HCMV) were compared for their sensitivity and specificity for detection of …
- 238000009396 hybridization 0 title abstract description 46
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cassol et al. | Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients. | |
Inaga et al. | Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients | |
Markowitz et al. | Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and-uninfected subjects | |
Azzi et al. | Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals | |
Nikkari et al. | Does parvovirus B19 have a role in rheumatoid arthritis? | |
Gozlan et al. | A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS | |
Peterlana et al. | Serologic and molecular detection of human Parvovirus B19 infection | |
US20060160087A1 (en) | Monitoring and treatment of amyotrophic lateral sclerosis | |
Pedneault et al. | Detection of Epstein‐Barr virus in the brain by the polymerase chain reaction | |
Carrillo et al. | Long-term persistent infection of swine monocytes/macrophages with African swine fever virus | |
Drouet et al. | Polymerase chain reaction detection of human cytomegalovirus in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion | |
SCHWEIZER et al. | Absence of foamy virus DNA in Graves' disease | |
Jiwa et al. | Three sensitive methods for the detection of cytomegalovirus in lung tissue of patients with interstitial pneumonitis | |
Boerman et al. | Polymerase chain reaction and viral culture techniques to detect HSV in small volumes of cerebrospinal fluid; an experimental mouse encephalitis study | |
Einsele et al. | Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical samples | |
Pepin et al. | Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures | |
Daiminger et al. | Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction | |
Gleaves et al. | Detection of cytomegalovirus from clinical specimens in centrifugation culture by in situ DNA hybridization and monoclonal antibody staining | |
Musiani et al. | Rapid diagnosis of cytomegalovirus encephalitis in patients with AIDS using in situ hybridisation. | |
Dekaban et al. | Retroviruses and multiple sclerosis. II. Failure of gene amplification techniques to detect viral sequences unique to the disease | |
Ulrych et al. | Disseminated adenovirus disease in immunocompromised patient successfully treated with oral ribavirin: a case report | |
Gibson et al. | Use of a molecular probe for detecting JCV DNA directly in human brain material | |
Gendelman et al. | In situ hybridization for detection of viral nucleic acid in cell cultures and tissues | |
Gautheret et al. | Detection and variant identification of HHV-6 by a non-radioactive hybridization microplate assay for amplimers detection | |
Evans et al. | Comparison of three PCR techniques for detecting cytomegalovirus (CMV) DNA in serum, detection of early antigen fluorescent foci and culture for the diagnosis of CMV infection |